Clinical significance of head and neck squamous cell cancer biomarkers

Oral Oncology

Volumn 50, Issue 3, 2014, Pages 168-177

  Polanska, Hana ^a,b   Raudenska, Martina ^a,b   Gumulec, Jaromir ^a,b   Sztalmachova, Marketa ^a,b   Adam, Vojtech ^b,c   Kizek, Rene ^b,c   Masarik, Michal ^a,b  

^a MASARYK UNIVERSITY   (Czech Republic)

^b BRNO UNIVERSITY OF TECHNOLOGY   (Czech Republic)

^c MENDEL UNIVERSITY IN BRNO   (Czech Republic)

Author keywords

Cancer; Head and neck cancer; miRNA; Papillomavirus; Prognosis; Saliva; Tumor markers

Indexed keywords

CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; COLLAGENASE 3; CORTACTIN; CYCLOOXYGENASE 2; FIBROBLAST GROWTH FACTOR; GELATINASE A; GELATINASE B; HERMES ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 18; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; MELANOMA ANTIGEN; METALLOTHIONEIN; MICRORNA 107; MICRORNA 133B; MICRORNA 138; MICRORNA 139; MICRORNA 155; MICRORNA 26B; MICRORNA 31; OSTEOPONTIN; PROSTAGLANDIN E2; PROTEIN P53; SURVIVIN; TRANSCRIPTION FACTOR SNAIL; TUMOR MARKER; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

CANCER DIAGNOSIS; CANCER GENETICS; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE REGULATION; CHROMOSOME ABERRATION; DISEASE SPECIFIC SURVIVAL; DOWN REGULATION; GENE EXPRESSION; GENETIC ANALYSIS; GENOMICS; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HETEROZYGOSITY LOSS; HISTOLOGY; HUMAN; IN VITRO STUDY; LYMPH NODE METASTASIS; MALIGNANT TRANSFORMATION; MEDICAL HISTORY; META ANALYSIS (TOPIC); PRECURSOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SALIVA LEVEL; SIGNAL TRANSDUCTION; SURVIVAL RATE; TUMOR GROWTH; TUMOR INVASION; UPREGULATION; WART VIRUS;

CANCER; HEAD AND NECK CANCER; MIRNA; PAPILLOMAVIRUS; PROGNOSIS; SALIVA; TUMOR MARKERS;

CARCINOMA, SQUAMOUS CELL; EARLY DETECTION OF CANCER; GENE EXPRESSION; GENOMICS; HEAD AND NECK NEOPLASMS; HUMANS; PROGNOSIS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84893776133     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.12.008     Document Type: Review

References (160)

1. M. Ramos, S. Benavente, and J. Giralt Management of squamous cell carcinoma of the head and neck: updated European treatment recommendations Expert Rev Anticancer Ther 10 3 2010 339 344
2. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 Ca-a Cancer J Clin 55 2 2005 74 108
3. C.A. Benhamou, N. Laraqui, M. Touhami, A. Chekkoury, Y. Benchakroun, and R. Samlali et al. Tobacco and cancer of the larynx: a prospective survey of 58 patients Rev Laryngol Otol Rhinol (Bord) 113 4 1992 285 288
4. S. Marur, G. D'Souza, W.H. Westra, and A.A. Forastiere HPV-associated head and neck cancer: a virus-related cancer epidemic Lancet Oncol 11 8 2010 781 789
5. T. Yoshizaki, K. Endo, Q.C. Ren, N. Wakisaka, S. Murono, and A. Kondo et al. Oncogenic role of Epstein-Barr virus-encoded small RNAs (EBERs) in nasopharyngeal carcinoma Auris Nasus Larynx 34 1 2007 73 78
6. D.I. Kutler, A.D. Auerbach, J. Satagopan, P.F. Giampietro, S.D. Batish, and A.G. Huvos et al. High incidence of head and neck squamous cell carcinoma in patients with Fanconi Anemia Arch Otolaryngol-Head Neck Surgery 129 1 2003 106 112
7. P.K. Ha, S.S. Chang, C.A. Glazer, J.A. Califano, and D. Sidransky Molecular techniques and genetic alterations in head and neck cancer Oral Oncol 45 4-5 2009 335 339
8. M.M. Kim, and J.A. Califano Molecular pathology of head-and-neck cancer Int J Cancer 112 4 2004 545 553
9. Stadler ME, Patel MR, Couch ME, Hayes DN. Molecular Biology of Head and Neck Cancer: Risks and Pathways. Hematol Oncol Clin N Am 2008;22(6):1099-+.
10. J.W. Rainsbury, W. Ahmed, H.K. Williams, S. Roberts, V. Paleri, and H. Mehanna Prognostic biomarkers of survival in oropharyngeal squamous cell carcinoma: systematic review and meta-analysis Head Neck 35 7 2013 1048 1055
11. S.I. Pai, and W.H. Westra Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annual review of pathology-mechanisms of disease 2009 Annual Reviews Palo Alto p. 49-70
12. C.H. Chung, and M.L. Gillison Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications Clin Cancer Res 15 22 2009 6758 6762
13. C.A. Moody, and L.A. Laimins Human papillomavirus oncoproteins: pathways to transformation Nat Rev Cancer 10 8 2010 550 560
14. E.M. Smith, J.M. Ritchie, K.F. Summersgill, J.P. Klussmann, J.H. Lee, and D.H. Wang et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers Int J Cancer 108 5 2004 766 772
15. J.P. Klussmann, S.J. Weissenborn, U. Wieland, V. Dries, J. Kolligs, and M. Jungehuelsing et al. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas Cancer 92 11 2001 2875 2884
16. M.S. Barbosa, D.R. Lowy, and J.T. Schiller Papillomavirus polypeptide-E6 and polypeptide-E7 are zinc-binding proteins J Virol 63 3 1989 1404 1407
17. H. Katori, A. Nozawa, and M. Tsukuda Relationship between p21 and p53 expression, human papilloma virus infection and malignant transformation in sinonasal-inverted papilloma Clin Oncol 18 4 2006 300 305
18. A. Vega-Pena, B. Illades-Aguiar, E. Flores-Alfaro, E. Lopez-Bayghen, E. Reyes-Maldonado, and L.D. Alarcon-Romero Correlation between Ki-67 and telomerase expression with in situ hybridization for high-risk human papillomavirus Arch Biol Sci 65 1 2013 81 90
19. K.K. Ang, J. Harris, R. Wheeler, R. Weber, D.I. Rosenthal, and P.F. Nguyen-Tan et al. Human papillomavirus and survival of patients with oropharyngeal cancer New Engl J Med 363 1 2010 24 35
20. M.B. Gillespie, S. Rubinchik, B. Hoel, and N. Sutkowski Human papillomavirus and oropharyngeal cancer: what you need to know in 2009 Curr Treat Options Oncol 10 5-6 2009 296 307
21. J.R. Nevins E2F - a link between the rb tumor suppressor protein and viral oncoproteins Science 258 5081 1992 424 429
22. N. Dyson, P.M. Howley, K. Munger, and E. Harlow The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene-product Science 243 4893 1989 934 937
23. C.A. Fischer, M. Jung, I. Zlobec, E. Green, C. Storck, and L. Tornillo et al. Co-overexpression of p21 and Ki-67 in head and neck squamous cell carcinoma relative to a significantly poor prognosis Head Neck-J Sci Special Head Neck 33 2 2011 267 273
24. H.C. Hafkamp, J.J. Mooren, S.M.H. Claessen, B. Klingenberg, A.C. Voogd, and F.J. Bot et al. P21(Cip1/WAF1) expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis Mod Pathol 22 5 2009 686 698
25. M.L. Gillison, and K.V. Shah Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers Curr Opin Oncol 13 3 2001 183 188
26. S.M. Dong, D.I. Sun, N.E. Benoit, I. Kuzmin, M.I. Lerman, and D. Sidransky Epigenetic inactivation of RASSF1A in head and neck cancer Clin Cancer Res 9 10 2003 3635 3640
27. D. Koutsimpelas, W. Pongsapich, U. Heinrich, S. Mann, W.J. Mann, and J. Brieger Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells Oncol Rep 27 4 2012 1135 1141
28. H. Donninger, M.D. Vos, and G.J. Clark The RASSF1A tumor suppressor J Cell Sci 120 18 2007 3163 3172
29. C. Laronga, H.Y. Yang, C. Neal, and M.H. Lee Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression J Biol Chem 275 30 2000 23106 23112
30. H.L. Yang, R.Y. Zhao, and M.H. Lee 14-3-3 Sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma Mol Cancer Ther 5 2 2006 253 260
31. B. Yi, S.X. Tan, C.E. Tang, W.G. Huang, A.L. Cheng, and C. Li et al. Inactivation of 14-3-3 sigma by promoter methylation correlates with metastasis in nasopharyngeal carcinoma J Cell Biochem 106 5 2009 858 866
32. R.J.C. Slebos, Y.J. Yi, K. Ely, J. Carter, A. Evjen, and X.Q. Zhang et al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma Clin Cancer Res 12 3 2006 701 709
33. D. Pyeon, N.A. Newton, P.F. Lambert, J.A. den Boon, S. Sengupta, and C.J. Marsit et al. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers Cancer Res 67 10 2007 4605 4619
34. B.J.M. Braakhuis, C.R. Leemans, and R.H. Brakenhoff A genetic progression model of oral cancer: current evidence and clinical implications J Oral Pathol Med 33 6 2004 317 322
35. J. Califano, P. vander Riet, W. Westra, H. Nawroz, G. Clayman, and S. Piantadosi et al. Genetic progression model for head and neck cancer: implications for field cancerization Cancer Res 56 11 1996 2488 2492
36. V.M.M. van Houten, C.R. Leemans, J.A. Kummer, J. Dijkstra, D.J. Kuik, and M.W.M. van den Brekel et al. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: A prospective study Clin Cancer Res 10 11 2004 3614 3620
37. M.P. Tabor, R.H. Brakenhoff, H.J. Ruijter-Schippers, J.A. Kummer, C.R. Leemans, and B.J.M. Braakhuis Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study Clin Cancer Res 10 11 2004 3607 3613
38. C.F. Poh, L. Zhang, D.W. Anderson, J.S. Durham, R.M. Williams, and R.W. Priddy et al. Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients Clin Cancer Res 12 22 2006 6716 6722
39. D. Roblyer, C. Kurachi, V. Stepanek, M.D. Williams, A.K. El-Naggar, and J.J. Lee et al. Objective detection and delineation of oral neoplasia using autofluorescence imaging Cancer Prev Res (Phila Pa) 2 5 2009 423 431
40. T.B.M. Schaaij-Visser, A.P. Graveland, S. Gauci, B.J.M. Braakhuis, M. Buijze, and A.J.R. Heck et al. Differential proteomics identifies protein biomarkers that predict local relapse of head and neck squamous cell carcinomas Clin Cancer Res 15 24 2009 7666 7675
41. J. Sudbo, M. Bryne, A.C. Johannessen, W. Kildal, H.E. Danielsen, and A. Reith Comparison of histological grading and large-scale genomic status (DNA ploidy) as prognostic tools in oral dysplasia J Pathol 194 3 2001 303 310 (Retracted Article. See vol. 211, 2007, p. 109)
42. J. Sudbo, W. Kildal, A.C. Johannessen, H.S. Koppang, A. Sudo, and H.E. Danielsen et al. Gross genomic aberrations in precancers: clinical implications of a long-term follow-up study in oral erythroplakias J Clin Oncol 20 2 2002 456 462
43. D.S. Rickman, R. Millon, A. De Reynies, E. Thomas, C. Wasylyk, and D. Muller et al. Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays Oncogene 27 51 2008 6607 6622
44. P. Cairns, T.J. Polascik, Y. Eby, K. Tokino, J. Califano, and A. Merlo et al. Frequency of homozygous deletion at P16/CDKN2 in primary human tumors Nat Genet 11 2 1995 210 212
45. A. Forastiere, W. Koch, A. Trotti, and D. Sidransky Medical progress - head and neck cancer New Engl J Med 345 26 2001 1890 1900
46. J.R. Grandis, D.J. Tweardy, and M.F. Melhem Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma Clin Cancer Res 4 1 1998 13 20
47. J.R. Grandis, and D.J. Tweardy Elevated levels of transforming growth-factor-alpha and epidermal growth-factor receptor messenger-rna are early markers of carcinogenesis in head and neck-cancer Cancer Res 53 15 1993 3579 3584
48. M.P. Tabor, B.J.M. Braakhuis, J.E. van der Wal, P.J. van Diest, C.R. Leemans, and R.H. Brakenhoff et al. Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx J Pathol 199 3 2003 354 360
49. P. Jares, P.L. Fernandez, E. Campo, A. Nadal, F. Bosch, and G. Aiza et al. PRAD-1 cyclin D1 gene amplification correlates with messenger-rna overexpression and tumor progression in human laryngeal carcinomas Cancer Res 54 17 1994 4813 4817
50. T. Callender, A.K. Elnaggar, M.S. Lee, R. Frankenthaler, H.A. Luna, and J.G. Batsakis PRAD-1 (CCND1) cyclin D1 oncogene amplification in primary head and neck squamous-cell carcinoma Cancer 74 1 1994 152 158
51. A.A. Molinolo, P. Amornphimoltham, C.H. Squarize, R.M. Castilho, V. Patel, and J.S. Gutkind Dysregulated molecular networks in head and neck carcinogenesis Oral Oncol 45 4-5 2009 324 334
52. E. Ioachim, D. Assimakopoulos, D. Peschos, A. Zissi, A. Skevas, and N.J. Agnantis Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen Pathol Res Pract 195 12 1999 809 814
53. M. Masarik, N. Cernei, P. Majzlik, D. Huska, H. Binkova, and V. Adam et al. Level of metallothionein, glutathione and heat-stable proteins in tumours from patients with head and neck cancer Int J Mol Med 26 2010 p. S46-S46
54. J. Sochor, D. Hynek, L. Krejcova, I. Fabrik, S. Krizkova, and J. Gumulec et al. Study of metallothionein role in spinocellular carcinoma tissues of head and neck tumours using brdicka reaction Int J Electrochem Sci 7 3 2012 2136 2152
55. L. Krejcova, I. Fabrik, D. Hynek, S. Krizkova, J. Gumulec, and M. Ryvolova et al. Metallothionein electrochemically determined using brdicka reaction as a promising blood marker of head and neck malignant tumours Int J Electrochem Sci 7 3 2012 1767 1784
56. M. Dutsch-Wicherek, A. Lazar, R. Tomaszewska, W. Kazmierczak, and L. Wicherek Analysis of metallothionein and vimentin immunoreactivity in pharyngeal squamous cell carcinoma and its microenvironment Cell Tissue Res 352 2 2013 341 349
57. G. Chan, J.O. Boyle, E.K. Yang, F. Zhang, P.G. Sacks, and J.P. Shah et al. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck Cancer Res 59 5 1999 991 994
58. G.M. Tse, A.D. King, A.M.C. Yu, C.C.F. Lam, A.W.H. Chan, and G.G. Chen et al. Correlation of biomarkers in head and neck squamous cell carcinoma Otolaryngol-Head Neck Surgery 143 6 2010 795 800
59. L. Jiang, X. Zeng, H. Yang, Z. Wang, J. Shen, and J. Bai et al. Oral cancer overexpressed 1 (ORAOV1): a regulator for the cell growth and tumor angiogenesis in oral squamous cell carcinoma Int J Cancer 123 8 2008 1779 1786
60. M.K. Kashyap, A. Marimuthu, C.J.H. Kishore, S. Peri, S. Keerthikumar, and T.S.K. Prasad et al. Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers Cancer Biol Ther 8 1 2009 36 46
61. A. Carles, R. Millon, A. Cromer, G. Ganguli, F. Lemaire, and J. Young et al. Head and neck squamous cell carcinoma transcriptome analysis by comprehensive validated differential display Oncogene 25 12 2006 1821 1831
62. C. Jin, Y. Jin, D. Gisselsson, J. Wennerberg, T.S. Wah, and B. Stromback et al. Molecular cytogenetic characterization of the 11q13 amplicon in head and neck squamous cell carcinoma Cytogenet Genome Res 115 2 2006 99 106
63. W. Li, C. Wang, S.K. Juhn, F.G. Ondrey, and J. Lin Expression of fibroblast growth factor binding protein in head and neck cancer Arch Otolaryngol-Head Neck Surgery 135 9 2009 896 901
64. M.A. Huber, N. Kraut, J.E. Park, R.D. Schubert, W.J. Rettig, and R.U. Peter et al. Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors J Invest Dermatol 120 2 2003 182 188
65. E.F. Hensen, M.J. De Herdt, J.J. Goeman, J. Oosting, V.T.H.B.M. Smit, and C.J. Cornelisse et al. Gene-expression of metastasized versus non-metastasized primary head and neck squamous cell carcinomas: a pathway-based analysis BMC Cancer 8 2008
66. S. Temam, H. Kawaguchi, A.K. El-Naggar, J. Jelinek, H.L. Tang, and D.D. Liu et al. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer J Clin Oncol 25 16 2007 2164 2170
67. K.K. Ang, B.A. Berkey, X.Y. Tu, H.Z. Zhang, R. Katz, and E.H. Hammond et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma Cancer Res 62 24 2002 7350 7356
68. S. Kalyankrishna, and J.R. Grandis Epidermal growth factor receptor biology in head and neck cancer J Clin Oncol 24 17 2006 2666 2672
69. X.Q. Liu, Z.G. Chen, J.S. Yu, J. Xia, and X.F. Zhou MicroRNA profiling and head and neck cancer Comp Funct Genomics 2009
70. J. Liu, D.P. Lei, T. Jin, X.N. Zhao, G.J. Li, and X.L. Pan Altered expression of miR-21 and PTEN in human laryngeal and hypopharyngeal squamous cell carcinomas Asian Pac J Cancer Prev 12 10 2011 2653 2657
71. S. Marur, and A.A. Forastiere Head and neck cancer: Changing epidemiology, diagnosis, and treatment (vol. 83, 2008, p. 489) Mayo Clin Proc 83 5 2008 p. 604-604
72. J.R. Clark, N. Naranjo, J.H. Franklin, J. de Almeida, and P.J. Gullane Established prognostic variables in N0 oral carcinoma Otolaryngol-Head Neck Surgery 135 5 2006 748 753
73. C. Le Tourneau, M. Velten, G.M. Jung, G. Bronner, H. Flesch, and C. Borel Prognostic indicators for survival in head and neck squamous cell carcinomas: analysis of a series of 621 cases Head Neck-J Sci Special Head Neck 27 9 2005 801 808
74. M.A. Kuriakose, and N.P. Trivedi Sentinel node biopsy in head and neck squamous cell carcinoma Current Opin Otolaryngol Head Neck Surgery 17 2 2009 100 110
75. C.R. Leemans, R. Tiwari, J.J.P. Nauta, I. Vanderwaal, and G.B. Snow Recurrence at the primary site in head and neck-cancer and the significance of neck lymph-node metastases as a prognostic factor Cancer 73 1 1994 187 190
76. G. Mamelle, J. Pampurik, B. Luboinski, R. Lancar, A. Lusinchi, and J. Bosq Lymph-node prognostic factors in head and neck squamous-cell carcinomas Am J Surg 168 5 1994 494 498
77. B. Kumar, K.G. Cordell, J.S. Lee, F.P. Worden, M.E. Prince, and H.H. Tran et al. EGFR, p16, HPV titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer J Clin Oncol 26 19 2008 3128 3137
78. C. Fakhry, W.H. Westra, S.L.A. Cmelak, J.A. Ridge, H. Pinto, and A. Forastiere et al. Improved survival of patients with human papillomavirus- positive head and neck squamous cell carcinoma in a prospective clinical trial J Natl Cancer Inst 100 4 2008 261 269
79. C.C.R. Ragin, and E. Taioli Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis Int J Cancer 121 8 2007 1813 1820
80. L. Licitra, F. Perrone, P. Bossi, S. Suardi, L. Mariani, and R. Artusi et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma J Clin Oncol 24 36 2006 5630 5636
81. H.C. Hafkamp, J.J. Manni, A. Haesvoets, A.C. Voogd, M. Schepers, and F.J. Bot et al. Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas Int J Cancer 122 12 2008 2656 2664
82. W.H. Westra, J.M. Taube, M.L. Poeta, S. Begum, D. Sidransky, and W.M. Koch Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck Clin Cancer Res 14 2 2008 366 369
83. M.K. Sackett, I. Bairati, F. Meyer, E. Jobin, S. Lussier, and A. Fortin et al. Prognostic significance of cyclooxygenase-2 overexpression in glottic cancer Clin Cancer Res 14 1 2008 67 73
84. Z. Chen, B. Yan, and C. Van Waes The Role of the NF-kappaB transcriptome and proteome as biomarkers in human head and neck squamous cell carcinomas Biomark Med 2 4 2008 409 426
85. C.T. Allen, J.L. Ricker, Z. Chen, and C. Van Waes Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck Head Neck 29 10 2007 959 971
86. P.L. Zhang, P.K. Pellitteri, A. Law, P.A. Gilroy, G.C. Wood, and T.L. Kennedy et al. Overexpression of phosphorylated nuclear factor-kappa B in tonsillar squamous cell carcinoma and high-grade dysplasia is associated with poor prognosis Mod Pathol 18 7 2005 924 932
87. Z. Liu, X. Zhang, D. Huang, Y. Liu, X. Zhang, and L. Liu et al. Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance Med Oncol 29 5 2012 3381 3388
88. Z.D. Gu, J.Y. Li, M. Li, J. Gu, X.T. Shi, and Y. Ke et al. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma Am J Gastroenterol 100 8 2005 1835 1843
89. S. Hu, M. Arellano, P. Boontheung, J.H. Wang, H. Zhou, and J. Jiang et al. Salivary proteomics for oral cancer biomarker discovery Clin Cancer Res 14 19 2008 6246 6252
90. R.N.S. Sainger, M.H. Shah, A.A. Desai, S.N. Shukla, P.M. Shah, and S.D. Telang et al. Clinical significance of serum p53 antibodies in oral cancer Tumori 92 2 2006 134 139
91. Y. Yamazaki, I. Chiba, M. Ishikawa, C. Satoh, K.I. Notani, and Y. Ohiro et al. Serum p53 antibodies as a prognostic indicator in oral squamous cell carcinoma Odontology 96 1 2008 32 37
92. S. Warnakulasuriya, T. Soussi, R. Maher, N. Johnson, and M. Tavassoli Expression of p53 in oral squamous cell carcinoma is associated with the presence of IgG and IgA p53 autoantibodies in sera and saliva of the patients J Pathol 192 1 2000 52 57
93. J. Sato, J. Goto, T. Murata, S. Kitamori, Y. Yamazaki, and A. Satoh et al. Changes in saliva interleukin-6 levels in patients with oral squamous cell carcinoma Oral Surgery Oral Med Oral Pathol Oral Radiol Endodontol 110 3 2010 330 336
94. J. Sato, M. Ohuchi, K. Abe, T. Satoh, T. Abe, and Y. Yamazaki et al. Correlation between salivary interleukin-6 levels and early locoregional recurrence in patients with oral squamous cell carcinoma: preliminary study Head Neck-J Sci Special Head Neck 35 6 2013 889 894
95. S.A. Duffy, J.M.G. Taylor, J.E. Terrell, M. Islam, Y. Li, and K.E. Fowler et al. Interleukin-6 predicts recurrence and survival among head and neck cancer patients Cancer 113 4 2008 750 757
96. V. Brailo, V. Vucicevic-Boras, A. Cekic-Arambasin, I.Z. Alajbeg, A. Milenovic, and J. Lukac The significance of salivary interleukin 6 and tumor necrosis factor alpha in patients with oral leukoplakia Oral Oncol 42 4 2006 370 373
97. N.L. Rhodus, V. Ho, C.S. Miller, S. Myers, and F. Ondrey NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma Cancer Detect Prev 29 1 2005 42 45
98. M.A.R. St John, Y. Li, X.F. Zhou, P. Denny, C.M. Ho, and C. Montemagno et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma Arch Otolaryngol-Head Neck Surgery 130 8 2004 929 935
99. E.P. de Jong, H.W. Xie, G. Onsongo, M.D. Stone, X.B. Chen, and J.A. Kooren et al. Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions PLoS ONE 5 6 2010
100. Y.J. Jou, C.D. Lin, C.H. Lai, C.H. Chen, J.Y. Kao, and S.Y. Chen et al. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer Anal Chim Acta 681 1-2 2010 41 48
101. B.G. Zimmermann, and D.T. Wong Salivary mRNA targets for cancer diagnostics Oral Oncol 44 5 2008 425 429
102. O. Brinkmann, D.A. Kastratovic, M.V. Dimitrijevic, V.S. Konstantinovic, D.B. Jelovac, and J. Antic et al. Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population Oral Oncol 47 1 2011 51 55
103. B. Yang, S.M. O'Herrin, J. Wu, S. Reagan-Shaw, Y. Ma, and K.M.R. Bhat et al. MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines Cancer Res 67 20 2007 9954 9962
104. K.D. Lee, H.H. Lee, H.B. Joo, H.S. Lee, T.H. Yu, and H.K. Chang et al. Expression of MAGE A 1-6 mRNA in sputa of head and neck cancer patients - a preliminary report Anticancer Res 26 2B 2006 1513 1518
105. J. Ries, A. Agaimy, E. Vairaktars, Y. Kwon, F.W. Neukam, and L.H. Strassburg et al. Evaluation of MAGE-A expression and grade of dysplasia for predicting malignant progression of oral leukoplakia Int J Oncol 41 3 2012 1085 1093
106. A.A. Jungbluth, K.J. Busam, D. Kolb, K. Iversen, K. Coplan, and Y.T. Chen et al. Expression of MAGE-antigens in normal tissues and cancer Int J Cancer 85 4 2000 460 465
107. J. Ries, S. Schultze-Mosgau, F. Neukam, E. Diebel, and J. Wiltfang Investigation of the expression of melanoma antigen-encoding genes (MAGE-A1 to-A6) in oral squamous cell carcinomas to determine potential targets for gene-based cancer immunotherapy Int J Oncol 26 3 2005 817 824
108. M. Pastorcic-Grgic, B. Sarcevic, D. Dosen, A. Juretic, G.C. Spagnoli, and M. Grgic Prognostic value of MAGE-A and NY-ESO-1 expression in pharyngeal cancer Head Neck-J Sci. Special Head Neck 32 9 2010 1178 1184
109. C.J. Liu, S.C. Lin, C.C. Yang, H.W. Cheng, and K.W. Chang Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma Head Neck-J Sci Special Head Neck 34 2 2012 219 224
110. N.J. Park, H. Zhou, D. Elashoff, B.S. Henson, D.A. Kastratovic, and E. Abemayor et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection Clin Cancer Res 15 17 2009 5473 5477
111. B. Hathaway, D.P. Landsittel, W. Gooding, T.L. Whiteside, J.R. Grandis, and J.A. Siegfried et al. Multiplexed analysis of serum cytokines as biomarkers in squamous cell carcinoma of the head and neck patients Laryngoscope 115 3 2005 522 527
112. D.Y. Hong, B.J. Lee, J.C. Lee, J.S. Choi, S.G. Wang, and J.H. Ro Expression of VEGF, HGF, IL-6, IL-8, MMP-9, telomerase in peripheral blood of patients with head and neck squamous cell carcinoma Clin Exp Otorhinolaryngol 2 4 2009 186 192
113. S.G. Jaiswal, A.R. Gadbail, M.S. Chaudhary, G.R. Jaiswal, and M. Gawande Correlation of serum levels of vascular endothelial growth factor with TNM staging, histopathologic grading, and surgical therapy for oral squamous cell carcinoma Quintessence Int 42 9 2011 771 779
114. C.H. Druzgal, Z. Chen, N.T. Yeh, G.R. Thomas, F.G. Ondrey, and D.C. Duffey et al. A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma Head Neck-J Sci Special Head Neck 27 9 2005 771 784
115. K.P. Chang, H.K. Kao, C.C. Wu, K.H. Fang, Y.L. Chang, and Y.C. Huang et al. Pretreatment interleukin-6 serum levels are associated with patient survival for oral cavity squamous cell carcinoma Otolaryngol-Head Neck Surgery 148 5 2013 786 791
116. W.L. Wang, W.L. Chang, Y.C. Yeh, C.T. Lee, C.Y. Chang, and J.T. Lin et al. Concomitantly elevated serum matrix metalloproteinases 3 and 9 can predict survival of synchronous squamous cell carcinoma of the upper aero-digestive tract Mol Carcinog 52 6 2013 438 445
117. C. Kuropkat, S. Plehn, U. Herz, A.A. Dunne, H. Renz, and J.A. Werner Tumor marker potential of serum matrix metalloproteinases in patients with head and neck cancer Anticancer Res 22 4 2002 2221 2227
118. C.Y. Yen, C.H. Chen, C.H. Chang, H.F. Tseng, S.Y. Liu, and L.Y. Chuang et al. Matrix metalloproteinases (MMP) 1 and MMP10 but not MMP12 are potential oral cancer markers Biomarkers 14 4 2009 244 249
119. P.Y. Chang, Y.B. Kuo, T.L. Wu, C.T. Liao, Y.C. Sun, and T.C. Yen et al. Association and prognostic value of serum inflammation markers in patients with leukoplakia and oral cavity cancer Clin Chem Lab Med 51 6 2013 1291 1300
120. F. Linkov, A. Lisovich, Z. Yurkovetsky, A. Marrangoni, L. Velikokhatnaya, and B. Nolen et al. Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling Cancer Epidemiol Biomark Prev 16 1 2007 102 107
121. N. Nohata, T. Hanazawa, T. Kinoshita, Y. Okamoto, and N. Seki MicroRNAs function as tumor suppressors or oncogenes: aberrant expression of microRNAs in head and neck squamous cell carcinoma Auris Nasus Larynx 40 2 2013 143 149
122. X. Leon, M. Quer, S. Diez, C. Orus, A. Lopez-Pousa, and J. Burgues Second neoplasm in patients with head and neck cancer Head Neck-J Sci Special Head Neck 21 3 1999 204 210
123. D.P. Slaughter, H.W. Southwick, and W. Smejkal Field cancerization in oral stratified squamous epithelium - clinical implications of multicentric origin Cancer 6 5 1953 963 968
124. V. Hayry, L.K. Makinen, T. Atula, H. Sariola, A. Makitie, and I. Leivo et al. Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue Br J Cancer 102 5 2010 892 897
125. A. Christopoulos, S.M. Ahn, J.D. Klein, and S. Kim Biology of vascular endothelial growth factor and its receptors in head and neck cancer: beyond angiogenesis Head Neck-J Sci Special Head Neck 33 8 2011 1220 1229
126. Suda T, Hama T, Kondo S, Yuza Y, Yoshikawa M, Urashima M, et al. Copy number amplification of the PIK3CA Gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma. BMC Cancer, vol. 12; 2012.
127. I. Fenic, K. Steger, C. Gruber, C. Arens, and J. Woenckhaus Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma Oncol Rep 18 1 2007 253 259
128. C. Sayar, H. Sayar, S. Ozdemir, T. Selcuk, O. Gorgulu, and Y. Akbas et al. Cyclooxygenase-2 expression and clinical parameters in laryngeal squamous cell carcinoma, vocal fold nodule, and laryngeal atypical hyperplasia Head Neck-J Sci Special Head Neck 35 1 2013 52 56
129. I. Anagnostopoulos, and M. Hummel Epstein-Barr virus in tumours Histopathology 29 4 1996 297 315
130. J.C. Lin, W.Y. Wang, W.M. Liang, H.Y. Chou, J.S. Jan, and R.S. Jiang et al. Long-term prognostic effects of plasma Epstein-Barr virus DNA by minor groove binder-probe real-time quantitative PCR on nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy Int J Radiat Oncol Biol Phys 68 5 2007 1342 1348
131. M. Ueda, T. Shimada, Y. Goto, K. Tei, S. Nakai, and Y. Hisa et al. Expression of CC-chemokine receptor 7 (CCR7) and CXC-chemokine receptor 4 (CXCR4) in head and neck squamous cell carcinoma Auris Nasus Larynx 37 4 2010 488 495
132. D.L. Ou, H.F. Chien, C.L. Chen, T.C. Lin, and L.I. Lin Role of Twist in head and neck carcinoma with lymph node metastasis Anticancer Res 28 2B 2008 1355 1359
133. Z.J. Shang, K. Liu, and Z. Shao Expression of chemokine receptor CCR7 is associated with cervical lymph node metastasis of oral squamous cell carcinoma Oral Oncol 45 6 2009 480 485
134. I. Yuce, A. Bayram, S. Cagli, O. Canoz, S. Bayram, and E. Guney The role of CD44 and matrix metalloproteinase-9 expression in predicting neck metastasis of supraglottic laryngeal carcinoma Am J Otolaryngol 32 2 2011 141 146
135. J.T. Lin, T.H. Chang, C.S. Chang, W.H. Wang, B.W. Su, and K.D. Lee et al. Prognostic value of pretreatment CD44 mRNA in peripheral blood of patients with locally advanced head and neck cancer Oral Oncol 46 5 2010 E29 E33
136. S.J. Wang, G. Wong, A.M. de Heer, W.L. Xia, and L.Y.W. Bourguignon CD44 variant isoforms in head and neck squamous cell carcinoma progression Laryngoscope 119 8 2009 1518 1530
137. C.H. Chen, C.Y. Chien, C.C. Huang, C.F. Hwang, H.C. Chuang, and F.M. Fang et al. Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity Oncogene 28 30 2009 2723 2737
138. C.H. Kim, Y.W. Koh, J.H. Han, J.W. Kim, J.S. Lee, and S.J. Baek et al. C-MET expression as an indicator of survival outcome in patients with oral tongue carcinoma Head Neck-J Sci Special Head Neck 32 12 2010 1655 1664
139. S. Yamada, S. Yanamoto, G. Kawasaki, A. Mizuno, and T.K. Nemoto Overexpression of cortactin increases invasion potential in oral squamous cell carcinoma Pathol Oncol Res 16 4 2010 523 531
140. J.P. Rodrigo, D. Garcia-Carracedo, L.A. Garcia, S.T. Menendez, E. Allonca, and M.V. Gonzalez et al. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas J Pathol 217 4 2009 516 523
141. P. Hofman, C. Butori, K. Havet, V. Hofman, E. Selva, and N. Guevara et al. Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status Br J Cancer 98 5 2008 956 964
142. J.H. Gibcus, M. Mastik, L. Menkema, G.H. de Bock, P.M. Kluin, and E. Schuuring et al. Cortactin expression predicts poor survival in laryngeal carcinoma Br J Cancer 98 5 2008 950 955
143. C.T. Tan, C.Y. Chu, Y.C. Lu, C.C. Chang, B.R. Lin, and H.H. Wu et al. CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway Carcinogenesis 29 8 2008 1519 1527
144. M. Xu, W.Y. Li, Y.H. Xu, and X.M. Chen Expression of CXCR4 in oral squamous cell carcinoma: correlations with clinicopathology and pivotal role of proliferation J Oral Pathol Med 39 1 2010 63 68
145. V. Patel, D. Martin, R. Malhotra, C.A. Marsh, C.L. Doci, and T.D. Veenstra et al. DSG3 as a biomarker for the ultrasensitive detection of occult lymph node metastasis in oral cancer using nanostructured immunoarrays Oral Oncol 49 2 2013 93 101
146. M.H. Yang, M.Z. Wu, S.H. Chiou, P.M. Chen, S.Y. Chang, and C.J. Liu et al. Direct regulation of TWIST by HIF-1 alpha promotes metastasis Nat Cell Biol 10 3 2008 295 305
147. M. Uehara, K. Sano, H. Ikeda, M. Nonaka, and I. Asahina Hypoxia-inducible factor 1 alpha in oral squamous cell carcinoma and its relation to prognosis Oral Oncol 45 3 2009 241 246
148. M.H. Yang, S.Y. Chang, S.H. Chiou, C.J. Liu, C.W. Chi, and P.M. Chen et al. Overexpression of NBS1 induces epithelial-mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer Oncogene 26 10 2007 1459 1467
149. C.J. Liu, K.W. Chang, S.C. Lin, and H.W. Cheng Presurgical serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinoma Oral Oncol 45 10 2009 920 925
150. D.S.S. Hsu, S.Y. Chang, C.J. Liu, C.H. Tzeng, K.J. Wu, and J.Y. Kao et al. Identification of increased NBS1 expression as a prognostic marker of squamous cell carcinoma of the oral cavity Cancer Sci 101 4 2010 1029 1037
151. C. Huang, K. Huang, C. Wang, Z.D. Jiang, X.X. Li, and H.P. Wang et al. Overexpression of mitogen-activated protein kinase kinase 4 and nuclear factor-kappaB in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis Oncol Rep 22 1 2009 89 95
152. M. Yan, Q. Xu, P. Zhang, X.J. Zhou, Z.Y. Zhang, and W.T. Chen Correlation of NF-kappaB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma BMC Cancer 10 2010 437
153. S.M. Kang, S. Elf, K. Lythgoe, T. Hitosugi, J. Taunton, and W. Zhou et al. P90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells J Clin Invest 120 4 2010 1165 1177
154. T. Ito, Y. Hashimoto, E. Tanaka, T. Kan, S. Tsunoda, and F. Sato et al. An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo Clin Cancer Res 12 4 2006 1308 1316
155. Y.H. Kim, S.M. Kim, Y.K. Kim, S.P. Hong, M.J. Kim, and H. Myoung Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma J Oral Pathol Med 39 5 2010 368 375
156. J.Z. Lin, Z. Guan, C.A. Wang, L. Feng, Y.Q. Zheng, and E. Caicedo et al. Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-kappa B/Survivin and Phosphoinositide 3-Kinase/Akt Signaling Pathways Clin Cancer Res 16 1 2010 77 87
157. Q. Wang, P.C. Wu, R.S. Roberson, B.V. Luk, I. Ivanova, and E. Chu et al. Survivin and escaping in therapy-induced cellular senescence Int J Cancer 128 7 2011 1546 1558
158. Y.H. Joo, C.K. Jung, M.S. Kim, and D.I. Sun Relationship between vascular endothelial growth factor and Notch1 expression and lymphatic metastasis in tongue cancer Otolaryngol-Head Neck Surgery 140 4 2009 512 518
159. G.M. Tse, A.W. Chan, K.H. Yu, A.D. King, K.T. Wong, and G.G. Chen et al. Strong immunohistochemical expression of vascular endothelial growth factor predicts overall survival in head and neck squamous cell carcinoma Ann Surg Oncol 14 12 2007 3558 3565
160. P. O-charoenrat, P. Rhys-Evans, and S.A. Eccles Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis Cancer 92 3 2001 556 568